{"id":69029,"date":"2026-03-13T12:12:34","date_gmt":"2026-03-13T12:12:34","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69029"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"ss-31-elamipretide","status":"publish","type":"product","link":"https:\/\/medsbase.com\/fr\/product\/ss-31-elamipretide\/","title":{"rendered":"SS-31 (Elamipretide)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u00e9ponse rapide \u2014 Qu'est-ce que le SS-31 (Elamipretide) ?<\/h3>\n<p style=\"margin: 0;\"><strong>SS-31<\/strong> (\u00e9galement appel\u00e9 <strong>Elamipretide<\/strong> ou <strong>Bendavia<\/strong>) est un t\u00e9trapeptide synth\u00e9tique qui se lie s\u00e9lectivement <strong>cardiolipine<\/strong> on the inner mitochondrial membrane, stabilizing mitochondrial function under stress. Developed by the Szeto-Schiller lab and now in late-stage clinical development by Stealth BioTherapeutics with FDA orphan-drug designation for rare mitochondrial disease. Supplied in 5\u00a0mg to 50\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce que vous obtenez avec MedsBase :<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Chaque commande est couverte par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\"><strong>Politique de R\u00e9exp\u00e9ditions Garanties<\/strong><\/a> \u2014 si votre colis n'arrive pas dans les 20 jours ouvrables, nous le r\u00e9exp\u00e9dions.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Sp\u00e9cification<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">D\u00e9tail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u00e9ro CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">736992-21-5<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formule mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>32<\/sub>H<sub>49<\/sub>N<sub>9<\/sub>O<sub>5<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">639.80 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Arg-2\u2032,6\u2032-Dmt-Lys-Phe-NH<sub>2<\/sub> (Bendavia, MTP-131)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Poudre lyophilis\u00e9e (ou tel que fourni)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puret\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599 % (v\u00e9rifi\u00e9 par HPLC, COA sur demande)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Stockage<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilis\u00e9 : 2\u20138 \u00b0C (r\u00e9frig\u00e9rateur) pour le stock de travail ; \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Reconstitu\u00e9 : 2\u20138 \u00b0C, \u00e0 utiliser dans ~30 jours. Prot\u00e9ger de la lumi\u00e8re. Ne pas congeler-d\u00e9congeler la solution reconstitu\u00e9e.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Eau bact\u00e9riostatique (recommand\u00e9e) ou eau st\u00e9rile pour des fen\u00eatres d'utilisation plus courtes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Qu'est-ce que le SS-31 (Elamipretide) ?<\/h2>\n<p><strong>SS-31<\/strong> est un t\u00e9trapeptide synth\u00e9tique perm\u00e9able aux cellules (D-Arg-2\u20196\u2032-dimethyl-L-Tyr-L-Lys-L-Phe, \u00e9galement abr\u00e9g\u00e9 <strong>Szeto-Schiller 31<\/strong>) d\u00e9velopp\u00e9 par Hazel Szeto et Peter Schiller au Weill Medical College de Cornell \u00e0 partir des ann\u00e9es 1990. Il est \u00e9galement connu sous ses noms de d\u00e9veloppement pharmaceutique <strong>Elamipretide<\/strong> et <strong>Bendavia<\/strong>, et est en d\u00e9veloppement clinique par <strong>Stealth BioTherapeutics<\/strong>. Unlike most peptides that bind cell-surface receptors, SS-31 is a <strong>agent ciblant les mitochondries<\/strong> qui traverse les membranes cellulaires et organellaires pour atteindre la membrane mitochondriale interne, o\u00f9 il se lie <strong>cardiolipine<\/strong> \u2014 a phospholipid unique to that location. This selective lipid binding underpins its mechanism of action and distinguishes SS-31 from virtually every other peptide. Molecular weight approximately 640\u00a0Da. SS-31 has <strong>D\u00e9signation de m\u00e9dicament orphelin par la FDA<\/strong> for primary mitochondrial myopathy and has been the subject of multiple human clinical trials \u2014 placing it further along the clinical development pipeline than most peptides. It is supplied here as a high-purity lyophilized powder <strong>for clinical studies use only<\/strong> (Stealth&#8217;s clinical product is a separate regulated therapeutic). For deeper mechanism, Szeto lab studies history, and clinical-trial context, see our <a href=\"https:\/\/medsbase.com\/fr\/ss-31-elamipretide-mitochondrial-guide\/\">SS-31 guide<\/a>. <\/p>\n<h2>M\u00e9canisme d'action \u2014 Stabilisation mitochondriale ciblant la cardiolipine<\/h2>\n<p>SS-31&#8217;s mechanism is unique among peptides because its target is a phospholipid, not a receptor protein. Three interconnected effects define its pharmacology:<\/p>\n<ul>\n<li><strong>Liaison \u00e0 la cardiolipine<\/strong> \u2014 Le SS-31 se lie s\u00e9lectivement \u00e0 la cardiolipine sur la membrane mitochondriale interne. La cardiolipine est un lipide signature trouv\u00e9 presque exclusivement \u00e0 cet endroit et est essentiel pour l'architecture des cr\u00eates (la surface repli\u00e9e de la membrane interne o\u00f9 se regroupent les complexes de la cha\u00eene de transport d'\u00e9lectrons). La liaison du SS-31 <strong>stabilise la morphologie des cr\u00eates<\/strong> lors d'un stress qui autrement provoquerait une perturbation des cr\u00eates et un dysfonctionnement mitochondrial.<\/li>\n<li><strong>R\u00e9duction des ROS et pr\u00e9servation de la cha\u00eene respiratoire<\/strong> \u2014 by preserving cristae architecture, SS-31 maintains the proper organization of electron-transport-chain complexes, preserving ATP synthesis and reducing electron &#8220;leakage&#8221; that generates reactive oxygen species. In ischemia-reperfusion study models, this translates to reduced oxidative damage and preserved mitochondrial function.<\/li>\n<li><strong>Pr\u00e9vention de la lib\u00e9ration du cytochrome c<\/strong> \u2014 mitochondrial apoptosis begins with cytochrome c release from the inner membrane space into the cytoplasm. By preserving cristae structure, SS-31 preserves cytochrome c localization and blocks a critical apoptotic trigger. This is central to its cardiac ischemia-reperfusion signal.<\/li>\n<\/ul>\n<p>The practical studies implication: SS-31 is the reference mitochondria-targeted peptide. Where other peptides act at cell-surface receptors, SS-31 acts inside the organelle, preserving mitochondrial function in study models of metabolic stress, ischemia, and aging. <\/p>\n<h2>Published Evidence<\/h2>\n<p>SS-31 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Primary mitochondrial disease studies<\/strong> \u2014 rare mitochondrial myopathy studies including Barth syndrome; SS-31 has FDA orphan-drug designation for this indication<\/li>\n<li><strong>Cardiac studies<\/strong> \u2014 heart failure, ischemia-reperfusion, cardiomyopathy, and cardiotoxicity rescue studies (Szeto, AAPS J 2014)<\/li>\n<li><strong>Renal studies<\/strong> \u2014 acute kidney injury, ischemia-reperfusion, and chronic kidney disease studies (Birk et al., J Am Soc Nephrol 2013)<\/li>\n<li><strong>Aging studies<\/strong> \u2014 dysfonction mitochondriale li\u00e9e \u00e0 l'\u00e2ge, vieillissement du muscle squelettique (sarcop\u00e9nie) et marqueurs g\u00e9n\u00e9raux du vieillissement cellulaire<\/li>\n<li><strong>Neuroprotection studies<\/strong> \u2014 ischemic-stroke and neurodegeneration studies where mitochondrial dysfunction is a driver<\/li>\n<li><strong>Sarcopenia studies<\/strong> \u2014 skeletal-muscle mitochondrial function and age-related muscle loss studies<\/li>\n<li><strong>Comparative mitochondrial-agent studies<\/strong> \u2014 c\u00f4te \u00e0 c\u00f4te avec <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD+<\/a> (coenzyme mitochondrial) et MitoQ (un autre antioxydant ciblant les mitochondries) pour isoler le m\u00e9canisme<\/li>\n<\/ul>\n<p>For broader context on longevity and mitochondrial-compounds see the <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">catalogue de peptides<\/a>. <\/p>\n<h2>Forces et concentrations disponibles<\/h2>\n<p>MedsBase propose le SS-31 (Elamipretide) dans les tailles de flacons lyophilis\u00e9s suivantes :<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Concentration du flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cas d'utilisation typique<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tailles de conditionnement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, low-dose rodent work<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, extended rodent studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>50\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Large-scale studies, clinical-trial-matched doses (40 mg\/day), lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The 50\u00a0mg vial size matches the clinical-trial 40 mg\/day dose used in Stealth BioTherapeutics&#8217;s human studies. Preclinical rodent studies typically uses smaller vials matched to 1\u20135 mg\/kg body weight. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>Comparaison \u2014 SS-31 vs autres compos\u00e9s mitochondriaux \/ de long\u00e9vit\u00e9<\/h2>\n<p>SS-31 is part of a small but growing class of mitochondria-targeted studies agents. Key comparisons:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e8re<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">SS-31 (Elamipretide)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD+<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epitalon<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Cible principale<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cardiolipine (lipide de la membrane mitochondriale interne)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sirtuines, enzymes PARP, cha\u00eene respiratoire<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Expression g\u00e9nique, signalisation pin\u00e9ale<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Preuves m\u00e9canistiques<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Solides (multiples laboratoires, essais cliniques)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tr\u00e8s solides (biochimie bien caract\u00e9ris\u00e9e)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Groupe restreint (Khavinson)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Statut clinique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">M\u00e9dicament orphelin FDA, Phase 3 (syndrome de Barth)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Non approuv\u00e9 (usage en th\u00e9rapie intraveineuse)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Non approuv\u00e9<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Isch\u00e9mie cardiaque, r\u00e9nale, sarcop\u00e9nie<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Long\u00e9vit\u00e9, \u00e9nergie, r\u00e9paration de l'ADN<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">T\u00e9lom\u00e8re, circadien<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose typique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201340 mg par jour (clinique) ; 1\u20135 mg\/kg (pr\u00e9clinique)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50\u2013100 mg par jour<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201310 mg par voie SC quotidiennement<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>SS-31 is distinct because it is the only peptide targeting a mitochondrial lipid directly. Users often study it alongside <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD+<\/a> (pour une couverture compl\u00e9mentaire de la voie des sirtuines) et <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> in multi-pathway longevity protocols. <\/p>\n<h2>Stockage et reconstitution<\/h2>\n<p><strong>Avant la reconstitution :<\/strong> conserver les flacons lyophilis\u00e9s au r\u00e9frig\u00e9rateur entre 2 et 8 \u00b0C dans leur emballage d'origine, stables jusqu'\u00e0 36 mois. \u00c9viter les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation de la poudre. <strong>Proc\u00e9dure de reconstitution :<\/strong> injecter de l'eau bact\u00e9riostatique le long de la paroi du flacon de peptide selon le tableau ci-dessus. Agiter doucement \u2014 ne pas <strong>re\u00e7oit pas<\/strong> secouer \u2014 et laisser 5 \u00e0 10 minutes pour une dissolution compl\u00e8te. La solution doit \u00eatre claire et incolore. <strong>Apr\u00e8s reconstitution :<\/strong> conserver au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C et utiliser dans les 30 jours. Ne pas congeler la solution reconstitu\u00e9e. <\/p>\n<h2 id=\"faqs\">Questions fr\u00e9quemment pos\u00e9es<\/h2>\n<h3>What is SS-31 used for in studies?<\/h3>\n<p>SS-31 (Elamipretide) is used in studies investigating mitochondrial disease (including Barth syndrome), cardiac ischemia-reperfusion, heart failure, acute kidney injury, chronic kidney disease, age-related mitochondrial dysfunction, sarcopenia, and neuroprotection. It has FDA orphan-drug designation but is <strong>re\u00e7oit pas<\/strong> yet FDA-approved for therapeutic use. Sold here strictly for clinical studies use only. <\/p>\n<h3>How is SS-31 different from other peptides?<\/h3>\n<p>SS-31 est unique car sa cible est <strong>cardiolipine<\/strong> \u2014 a phospholipid on the inner mitochondrial membrane \u2014 not a cell-surface receptor. It is cell-permeable and reaches the mitochondrial matrix to stabilize cristae architecture and preserve electron-transport-chain function. Virtually every other peptide binds receptors on the cell surface. <\/p>\n<h3>What is the typical SS-31 dose?<\/h3>\n<p>Stealth BioTherapeutics&#8217; clinical trials have used 40\u00a0mg SC daily. Preclinical rodent studies typically uses 1\u20135\u00a0mg\/kg body weight daily. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5.0\u00a0mg\/mL \u2014 100 ticks on a U-100 syringe delivers 5\u00a0mg. <\/p>\n<h3>SS-31 est-il approuv\u00e9 par la FDA ?<\/h3>\n<p>SS-31 (Elamipretide) a re\u00e7u la d\u00e9signation de m\u00e9dicament orphelin par la FDA pour la myopathie mitochondriale primaire et est en d\u00e9veloppement clinique avanc\u00e9 par Stealth BioTherapeutics. Il n'est <strong>re\u00e7oit pas<\/strong> yet fully FDA-approved. All SS-31 sold by specialist suppliers is for clinical investigation, not the clinical-trial therapeutic product. <\/p>\n<h3>Que signifie l'abr\u00e9viation \u201c SS-31 \u201d ?<\/h3>\n<p>SS-31 signifie <strong>Szeto-Schiller compound 31<\/strong>, after the Cornell users Hazel Szeto and Peter Schiller who developed the SS-series of mitochondria-targeted peptides in the 1990s and 2000s. The &#8220;31&#8221; is simply the compound number in their synthesis series. The compound was later licensed to Stealth BioTherapeutics and renamed Elamipretide (and Bendavia) for clinical development. <\/p>\n<h3>Comment conserver SS-31 ?<\/h3>\n<p>Flacons lyophilis\u00e9s : r\u00e9frig\u00e9r\u00e9s \u00e0 2\u20138 \u00b0C dans leur emballage d'origine, stables jusqu'\u00e0 36 mois. Solution reconstitu\u00e9e : r\u00e9frig\u00e9r\u00e9e \u00e0 2\u20138 \u00b0C, \u00e0 utiliser dans les 30 jours. Ne pas congeler la solution reconstitu\u00e9e. <\/p>\n<h3>Comment reconstituer SS-31 ?<\/h3>\n<p>Suivez le tableau de reconstitution ci-dessus. Ajoutez de l'eau bact\u00e9riostatique le long de la paroi lat\u00e9rale du flacon, agitez doucement et laissez reposer 5 \u00e0 10 minutes pour une dissolution compl\u00e8te. Ne <strong>re\u00e7oit pas<\/strong> secouez pas. <\/p>\n<h3>Can SS-31 be stacked with NAD+ in studies?<\/h3>\n<p>Yes \u2014 this is a common multi-pathway mitochondrial studies combination. SS-31 stabilizes cristae architecture and cardiolipin-dependent ETC function; <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD+<\/a> fournit un substrat coenzymatique pour la cha\u00eene de transport d'\u00e9lectrons et la signalisation sirtuine\/PARP en aval. Les m\u00e9canismes sont compl\u00e9mentaires et non redondants. <\/p>\n<h3>Quelles sont les dosages disponibles chez MedsBase ?<\/h3>\n<p>MedsBase carries SS-31 (Elamipretide) in 5\u00a0mg, 10\u00a0mg, and 50\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis on request. <\/p>\n<h3>Does SS-31 cause side reported effects?<\/h3>\n<p>Published preclinical and clinical-trial has reported a favorable safety profile. Most commonly reported effects in the clinical-trial literature are injection-site reactions. Because SS-31 has been studied in multiple human trials (Phase 2 and Phase 3), its safety profile is better-characterised than most peptides. <\/p>\n<h3>SS-31 est-il identique \u00e0 Bendavia ou Elamipretide ?<\/h3>\n<p>Oui. Le m\u00eame compos\u00e9 porte trois noms : <strong>SS-31<\/strong> (original Szeto-Schiller studies designation), <strong>Bendavia<\/strong> (nom de d\u00e9veloppement pr\u00e9coce de Stealth BioTherapeutics), et <strong>Elamipretide<\/strong> (international nonproprietary name \/ INN). Studies literature uses SS-31 predominantly; clinical-trial literature uses Elamipretide or Bendavia. <\/p>\n<h3>Quelle est la demi-vie de SS-31 ?<\/h3>\n<p>Le SS-31 (elamipretide) a une demi-vie plasmatique courte d'environ 30 \u00e0 60 minutes apr\u00e8s administration sous-cutan\u00e9e, mais pr\u00e9sente une accumulation mitochondriale prolong\u00e9e en raison de son affinit\u00e9 pour la cardiolipine dans la membrane mitochondriale interne. La demi-vie tissulaire dans les organes riches en mitochondries comme le muscle cardiaque et squelettique est estim\u00e9e \u00e0 plusieurs heures apr\u00e8s la clairance plasmatique. <\/p>\n<h3>Comment le SS-31 cible-t-il sp\u00e9cifiquement les mitochondries ?<\/h3>\n<p>Le SS-31 est un peptide Szeto-Schiller avec une structure aromatique-cationique altern\u00e9e (D-Arg-dimethyl-Tyr-Lys-Phe-NH\u2082). Cette s\u00e9quence entra\u00eene une accumulation dans la membrane mitochondriale interne environ 1 000 fois sup\u00e9rieure aux niveaux cytoplasmiques, m\u00e9di\u00e9e par une attraction \u00e9lectrostatique vers la phospholipide cardiolipine charg\u00e9e n\u00e9gativement. La liaison \u00e0 la cardiolipine stabilise les complexes de la cha\u00eene de transport d'\u00e9lectrons et r\u00e9duit la production d'esp\u00e8ces r\u00e9actives de l'oxyg\u00e8ne (ROS). <\/p>\n<h3>Puis-je commander du SS-31 pour une livraison internationale ?<\/h3>\n<p>Oui. MedsBase exp\u00e9die le SS-31 dans le monde entier depuis notre r\u00e9seau d\u00e9di\u00e9 d'exp\u00e9dition de peptides. Les commandes contenant uniquement des peptides sont \u00e9ligibles pour notre service d'exp\u00e9dition de peptides autonome. Les commandes sont exp\u00e9di\u00e9es dans un emballage \u00e0 temp\u00e9rature contr\u00f4l\u00e9e avec un suivi complet. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/fr\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/fr\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/fr\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agoniste s\u00e9lectif de la ghr\u00e9line \u2014 pic d'hormone de croissance propre sans cortisol\/prolactine<\/li>\n<li><a href=\"\/fr\/cjc-1295-with-dac\/\"><strong>CJC-1295 avec DAC<\/strong><\/a> \u2014 Analogue de GHRH avec demi-vie prolong\u00e9e<\/li>\n<li><a href=\"\/fr\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Pour en savoir plus<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lisez notre guide complet bas\u00e9 sur des preuves : <a href=\"https:\/\/medsbase.com\/fr\/ss-31-elamipretide-mitochondrial-guide\/\"><strong>SS-31 (Elamipretide) \u2014 cardiolipin targeting, mitochondrial studies &amp; clinical trials<\/strong><\/a>. Covers Szeto-Schiller mechanism studies, Stealth BioTherapeutics clinical development, cardiac\/renal\/neurological applications, and realistic context.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Am\u00e9liore l'\u00e9nergie cellulaire<br \/>\n\u2705 Soutient la fonction mitochondriale<br \/>\n\u2705 R\u00e9duit le stress oxydatif<br \/>\n\u2705 Am\u00e9liore la r\u00e9silience des tissus<br \/>\n\u2705 Favorise l'efficacit\u00e9 m\u00e9tabolique<\/p>\n<p><strong>SS-31<\/strong> contient un compos\u00e9 peptidique synth\u00e9tique.<\/p>","protected":false},"featured_media":70982,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5476,5475],"class_list":["post-69029","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-elamipretide","product_tag-ss-31","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product\/69029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/comments?post=69029"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media\/70982"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media?parent=69029"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=69029"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=69029"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=69029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}